Sign in →

Test ID HVDSP HIV-1 and HIV-2 Antibody Confirmation and Differentiation Prenatal, Plasma


Ordering Guidance


This test is not suitable for follow-up testing of patients with reactive results from any rapid HIV tests, except for pregnant patients who were reactive by the Determine HIV-1/-2 Ag/Ab Combo rapid point-of-care test on serum or plasma (but not whole blood). Per the latest CDC recommended HIV testing algorithm patients with reactive results from any rapid HIV tests should be tested subsequently with laboratory-based HIV antigen and antibody combination immunoassays, such as HIVSP / HIV Antigen and Antibody Prenatal Routine Screen, Plasma,.

 

If specimens are autopsy or cadaver blood sources, the proper FDA-licensed assay is HV1CD / HIV-1 and HIV-2 Antibodies for Cadaveric or Hemolyzed Specimens, Serum.

 

New York State clients: This test should not be requested for maternal/newborn HIV screening on specimens originating in New York State, due to state regulatory requirements for expedited result reporting.



Necessary Information


Date of collection is required.



Specimen Required


Supplies: Aliquot Tube, 5 mL (T465)

Collection Container/Tube: Lavender top (EDTA)

Submission Container/Tube: Plastic vial

Specimen Volume: 1 mL

Collection Instructions:

1. Centrifuge blood collection tube per collection tube manufacturer's instructions (eg, centrifuge and aliquot within 2 hours of collection for BD Vacutainer tubes).

2. Aliquot plasma into plastic vial.


Useful For

Confirmation and differentiation of HIV-1 and HIV-2 antibodies in plasma specimens from prenatal patients who show reactive results with 3rd- (HIV-1/-2 antibody only) and 4th-generation (HIV antigen and antibody) HIV serologic assays

 

This test is not useful as a screening test for HIV infection in symptomatic or asymptomatic individuals.

 

This test is not to be used as a screening or confirmatory test for blood donor specimens.

Testing Algorithm

This test is for confirmation and differentiation of HIV-1 and HIV-2 antibodies. If the following result types are obtained then prenatal HIV-1 RNA detection and quantification, will be performed at an additional charge:

-HIV-1 and HIV-2 both negative

-Indeterminate for HIV-1 and negative for HIV-2

-Negative for HIV-1 and indeterminate for HIV-2

-HIV-1 and HIV-2 both indeterminate

 

The following algorithms are available in Special Instructions:

-HIV Prenatal Testing Algorithm, Including Follow-up of Reactive Rapid Serologic Test Results

-HIV Testing Algorithm (Fourth-Generation Screening Assay), Including Neonatal Testing and Follow-up of Reactive Rapid Serologic Test Results

Method Name

Rapid Immunochromatographic Assay

Reporting Name

HIV Ab Differentiation Prenatal, P

Specimen Type

Plasma

Specimen Minimum Volume

0.8 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Plasma Frozen (preferred) 30 days
  Refrigerated  6 days

Reference Values

Negative

Day(s) Performed

Monday through Friday

Report Available

1 to 3 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test has been cleared, approved or is exempt by the U.S. Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.

CPT Code Information

86701

86702

LOINC Code Information

Test ID Test Order Name Order LOINC Value
HVDSP HIV Ab Differentiation Prenatal, P 89365-1

 

Result ID Test Result Name Result LOINC Value
91952 HIV-1 Ab Differentiation Prenatal, P 68961-2
91953 HIV-2 Ab Differentiation Prenatal, P 81641-3

NY State Approved

Yes

Reflex Tests

Test ID Reporting Name Available Separately Always Performed
HIQNP HIV-1 RNA Detect/Quant Prenatal, P Yes No